The Australian flag and the American flag juxtaposed alongside one another. Source: Adobe Stock
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Telix Pharmaceuticals (ASX:TLX) announced on Monday it has filed early-stage paperwork proposing to US regulators a listing on the American equities markets.

Morgan Stanley and Jefferies are among the firms acting as managers for the IPO process, signifying a high level of confidence from Telix it intends to go forward with the plan.

A US prospectus is already lined up for exclusive US release; Telix is ultimately aiming for the NASDAQ.

Notably, the move comes as the ASX experiences uncharacteristically quiet newsflow volumes through 2024 in an environment where bonds and commodities have seduced many away from domestic equities.

Telix is seeking to offer American Depository Shares (ADSs) under the ticker it uses down under, TLX.

TLX closed on Friday at A$14.80/sh.

TLX by the numbers
More From The Market Online
The Market Online Video

ASX Market Close: Consumer Discretionary rises ahead of interest rates decision | June 14, 2024

The ASX200 is down a third of a per cent to close the week. All sectors…
The Market Online Video

ASX Market Update: ASX slips 0.3%, Discretionary is the only sector to rise | 14 June, 2024

The ASX200 is trading down around 0.3%. The discretionary sector has made gains of 0.3%, all…

Week 24 Wrap: US contagion sentiment not so contagious; iron ore remains pressured

It was, overall, a lacklustre week for the ASX. We only saw one green day on…
The Market Online Video

Geology is King: Sun Silver says Maverick Springs will outshine high-grade Australian mines

Sun Silver Ltd (ASX:SS1) is seeking gold, silver and pathfinder elements at their Maverick Springs project…